Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.16
BATS BZX Real-Time Price
As of 11:56am ET
 +0.06 / +2.86%
Today’s Change
1.85
Today|||52-Week Range
4.19
-18.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$282.3M

Company Description

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.

Contact Information

Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington Massachusetts 02421
P:(781) 274-8200
Investor Relations:
(781) 541-7250

Employees

Shareholders

Individual stakeholders36.36%
Other institutional34.62%
Mutual fund holders13.66%

Top Executives

Chen SchorPresident, Chief Executive Officer & Director
Marc R. SchneebaumSenior VP, Chief Financial & Accounting Officer
Vojo VukovicChief Medical Officer & Senior Vice President
Dvorit SamidVice President-Medical Affairs
Wendy E. RiederSecretary, Senior Vice President & General Counsel